Name | Type | Posted | Actions |
|---|---|---|---|
FDA-SSN-75F40126Q00214.pdf | Jun 9, 2026 |
Virtual Plant for a Continuous Direct Compression Process– License Package Update Service for Process Automation Software, Engineering Software, and Virtual Controller Software
The Food and Drug Administration (FDA) Office of Pharmaceutical Quality and Research (OPQR) is seeking market information for license maintenance and software update services. These services support a Pharmaceutical Manufacturing Virtual Plant that uses a Continuous Direct Compression Process. The scope includes process automation, engineering, and virtual controller software, specifically the SIMATIC SIMIT, SIMATIC SIPAT, and PCS7 platforms. The FDA Office of Acquisitions and Grants Services is evaluating small business availability for a contract with a one-year base period and four one-year options. This phase includes gathering feedback on technical specifications and the proposed CLIN structure. Work will take place in Silver Spring, Maryland. The FDA Office of Pharmaceutical Quality and Research (OPQR) is identifying sources for license maintenance and software updates for its Pharmaceutical Manufacturing Virtual Plant. Maintenance and updates for process automation, engineering, and virtual controller software within the FDA's Pharmaceutical Manufacturing Virtual Plant.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.
Contact and place of performance
Terina Hicks
Silver Spring, MD 20993
USA
The FDA/OPQR requires license maintenance service update for process automation software and SIMATIC SIPAT (Siemens PAT) software update service for a Pharmaceutical Manufacturing Virtual Plant via SIMATIC SIMIT, SIMATIC SIPAT, and PCS7 (or equivalent) for a One-Year Base with Four-Year Options Period of Performance.
Please review the attached Sources Sought Notice FDA-SSN-75F40126Q00214 document for more information.